A Comparison of Immediate and Extended Release Venlafaxine Following Bariatric Surgery
Phase of Trial: Phase IV
Latest Information Update: 12 Apr 2016
Price : $35 *
At a glance
- Drugs Venlafaxine (Primary)
- Indications Anxiety disorders; Diabetic neuropathies; Generalised anxiety disorder; Major depressive disorder; Panic disorder; Social phobia
- Focus Pharmacokinetics
- 05 Apr 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 May 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
- 19 Dec 2013 New trial record